Natural menopause and surgical menopause might have different effects on cognitive function, according to the results of animal research published in the September issue of Endocrinology.
Natural menopause and surgical menopause might have different effects on cognitive function, according to the results of animal research published in the September issue of Endocrinology.
Jazmin I. Acosta, PhD, of Arizona State University in Tempe, and colleagues analyzed data from middle-aged female rats that underwent ovariectomy surgery; gradual ovarian follicular depletion with 4-vinylcyclohexene-diepoxide (leading to results resembling those in nonsurgically menopausal women); gradual ovarian follicular depletion with 4-vinylcyclohexene-diepoxide treatment followed by ovariectomy; or sham surgery. Rats were then given a battery of cognitive tests.
The researchers' results indicate that transitional menopause before ovariectomy may be associated with better memory than abrupt loss of hormones with the surgery. In addition, removal of ovaries after transitional ovarian hormone loss may be linked to better cognition compared to retaining the ovaries.
A co-author reported a financial relationship with Senestech Inc.
Acosta JI, Mayer L, Talbloom JS, et al. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology. 2009;150:4248-4259.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More